Delhi HC: Property Disputes Between In-Laws and Daughter-In-Law are Not Exclusively For Family Court || Delhi High Court: After Probate is Granted, A Will Does Not Require Fresh Proof under Section 68 || Ker HC: Periodic Replacement and Maintenance of Prosthetic Limb Must Be Included in Compensation || Madras High Court: DNA Test Not Required For Mother to Donate Kidney to Her Son || Delhi HC: Pre-Summoning Evidence Opportunity Must be Granted Even in Civil-Natured Criminal Cases || J&K&L HC: UAPA Trials Cannot Linger and Must Proceed With Day-To-Day Hearing under NIA Act || Allahabad HC: FIR in Disproportionate Assets Case Not Vitiated For Lack of Pre-Registration Hearing || Allahabad HC: FIR in Disproportionate Assets Case Not Vitiated For Lack of Pre-Registration Hearing || Delhi HC: Private Schools May Increase Fees Without Prior Approval if Declared Before Session Begins || Supreme Court: Omission of Accused in Inquest Report Alone Does Not Indicate Innocence

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :